Go to content

Incidence and severity of adverse events from treatment with adjuvant trastuzamab-based chemotherapy in HER2+ breast cancer patients

Project ID: 2016-045/2018 0950 011 000
Type of Response: Research project
Knowledge User: Cancer Care Ontario  
ICES Scientist: Craig Earle, Refik Saskin
Status: Completed